1 study found for:    DUAL-2
Show Display Options
Rank Status Study
1 Terminated Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
Conditions: Systemic Sclerosis;   Ulcers
Interventions: Drug: macitentan 3mg;   Drug: macitentan 10mg;   Drug: placebo

Indicates status has not been verified in more than two years